Your browser doesn't support javascript.
loading
Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration.
Zhang, Ao; Hitomi, Masahiro; Bar-Shain, Noah; Dalimov, Zafardjan; Ellis, Leigh; Velpula, Kiran K; Fraizer, Gail C; Gourdie, Robert G; Lathia, Justin D.
  • Zhang A; Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, OH, 44195, USA.
  • Hitomi M; Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
  • Bar-Shain N; Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, OH, 44195, USA.
  • Dalimov Z; Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
  • Ellis L; Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
  • Velpula KK; Genitourinary Program, Department of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo NY, 14263, USA.
  • Fraizer GC; Genitourinary Program, Department of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo NY, 14263, USA.
  • Gourdie RG; Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL, 61656, USA.
  • Lathia JD; Department of Biological Sciences, Kent State University, Kent, OH, 44242, USA.
Oncotarget ; 6(13): 11640-51, 2015 May 10.
Article en En | MEDLINE | ID: mdl-25960544

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Movimiento Celular / Conexina 43 Tipo de estudio: Risk_factors_studies Límite: Animals / Humans / Male Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Movimiento Celular / Conexina 43 Tipo de estudio: Risk_factors_studies Límite: Animals / Humans / Male Idioma: En Año: 2015 Tipo del documento: Article